Rare Diseases

With over 7000 rare diseases identified, affecting an estimated 260–440 million individuals worldwide, there is a critical need for specialized focus in this area. Approximately 95% of these

diseases lack FDA-approved treatments, highlighting a substantial unmet medical need.

Our expertise in rare diseases is aimed at bridging this gap – providing the insights needed to facilitate research,

and the strategic advisory necessary to ensure commercial success.